Filing Details

Accession Number:
0001181431-14-037802
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-03 17:42:25
Reporting Period:
2014-12-01
Filing Date:
2014-12-03
Accepted Time:
2014-12-03 17:42:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI Pharmaceutical Preparations (2834) 364742850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1299430 D Christopher Alafi C/O Alafi Capital Company, Llc
8 Admiral Drive, Suite 324
Emeryville CA 94608
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-01 1,422 $14.75 3,596,205 No 4 P Indirect Held by Alafi Capital Company, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Alafi Capital Company, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,010 Direct
Common Stock 503,753 Indirect Held as Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust
Footnotes
  1. Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
  2. Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.